The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Maternal Use of Antiepileptic Drugs and the Risk of Major Congenital Malformations: A Joint European Prospective Study of Human Teratogenesis Associated with Maternal Epilepsy
Open accessAbstract
Summary: Purpose: To quantify the risks of intrauterine antiepileptic drug (AED) exposure in monotherapy and poly‐therapy. Methods : Data from five prospective European studies totaling 1,379 children were pooled and reanalyzed. Data were available for 1,221 children exposed to AED during pregnancy and for 158 children of unexposed control pregnancies. Results : Overall, when comparing a subgroup of 192 children exposed to AED with 158 children of matched nonepileptic controls, there was an increased risk of major congenital malformations (MCA) in children exposed to AED during gestation [relative risk (RR) 2.3; 95% confidence interval (CI): 1.2–4.7]. A significant increase in risk was found for children exposed to valproate (VPA) (RR 4.9; 95% CI: 1.6–15.0) or carbamazepine (CBZ) (RR 4.9; 95% CI: 1.3–18.0) in monotherapy. When comparing different AED regimens during all 1,221 pregnancies, risks of MCA were significantly increased for the combination of phenobarbital (PB) and ethosuximide (RR 9.8; 95% CI: 1.4–67.3) and the combination of phenytoin, PB, CBZ, and VPA (RR 11.0; 95% CI: 2.1–57.6). Offspring of mothers using > 1,000 mg VPNday were at a significantly increased risk of MCA, especially neural tube defects, compared to offspring exposed ≥600 mg VPNday (RR 6.8; 95% CI: 1.4–32.7). No difference in risk of MCA was found between the offspring exposed to 601–1,000 mg/day and ≥600 mg/day. Conclusions : This reanalysis shows that VPA is consistently associated with an increased risk of MCA in babies born to mothers with epilepsy. Significant associations were also observed with CBZ. Larger prospective population‐based studies are needed to evaluate the risks of many other less frequently prescribed treatment regimens, including newly marketed AEDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AED use during pregnancy is associated with risks to the fetus as these drugs can cross the placenta or may be transferred to the infant through breast feeding and may be associated with adverse neurodevelopment outcomes.2–4”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS
Robert, E., & Guibaud, P. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90908-4 · Cited by 537
Nearly ubiquitous tissue distribution of the scrapie agent precursor protein
Bendheim, P. E., Brown, H. R., Rudelli, R. D., Scala, L. J., Goller, N. L., Wen, G. Y., Kascsak, R. J., Cashman, N. R., & Bolton, D. C. (1992) · Neurology · doi:10.1212/wnl.42.1.149 · Cited by 472
Spina Bifida in Infants of Women Treated with Carbamazepine during Pregnancy
Rosa, F. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241006 · Cited by 457
DiLiberti, J. H., Farndon, P. A., Dennis, N. R., & Curry, C. J. (1984) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320190308 · Cited by 397
IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTS
Lindhout, D., & Schmidt, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91711-3 · Cited by 300
Self-citationNatural History of Lactic Acidosis after Grand-Mal Seizures
Orringer, C. E., Eustace, J. C., Wunsch, C. D., & Gardner, L. B. (1977) · New England Journal of Medicine · doi:10.1056/nejm197710132971502 · Cited by 286
ANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTS
Shapiro, S., Hartz, S. C., Siskind, V., Mitchell, A. A., Slone, D., Rosenberg, L. A., Monson, R. R., Heinonen, O. P., Idänpään-Heikkilä, J. J., Häró, S., et al. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91403-3 · Cited by 270
The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
Omtzigt, J. G. C., Los, F. J., Grobbee, D. E., Pijpers, L., Jahoda, M. G. J., Brandenburg, H., Stewart, P. A., Gaillard, H. L., Sachs, E. S., & Wladimiroff, J. W. (1992) · PubMed · Cited by 252
Self-citationANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTS
Shapiro, S., Slone, D., Hartz, S. C., Rosenberg, L. A., Siskind, V., Monson, R. R., Mitchell, A. A., & Heinonen, O. P. (1976) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197608000-00012 · Cited by 245
Delgado‐Escueta, A. V., & Janz, D. (1992) · PubMed · Cited by 220
Self-citation
Research works printed but not linked: 4
- Hiilesmaa VK., 1982, A prospective study on maternal and fetal outcome in 139 women with epilepsy. Academic dissertation
- Klepel H, 1986, Untersuchungen zum pranatalen Wachsurn von Kindern anfallskranker Mutter, Psychiatr Neurol Med Psycho1, 38, 55
- Lindhout D., 1985, Teratogenesis in maternal epilepsy; new aspects of prevention
- Whittle BA., 1976, Clinical and pharmacological aspects of sodium valproate (Epilim) in treatment of epilepsy., 105
Cited by
Sorted by citations
Items 101–200 of 403
Kjaer, D., Horváth–Puhó, E., Christensen, J., Vestergaard, M., Czeizel, A. E., Sørensen, H. T., & Olsen, J. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1288 · Cited by 65
Raza, M., Shaheen, F., Choudhary, M. I., Sombati, S., Rafiq, A., Suria, A., Rahman, A., & DeLorenzo, R. J. (2001) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(01)00327-0 · Cited by 66
Ornoy, A., Echefu, B. E., & Becker, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010390 · Cited by 77
Drugs that affect the fetus and newborn infant via the placenta or breast milk
Ostrea, E. M., Mantaring, J. B., & Silvestre, M. A. A. (2004) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2004.01.001 · Cited by 63
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child
Bromley, R., Adab, N., Bluett‐Duncan, M., Clayton‐Smith, J., Christensen, J., Edwards, K., Greenhalgh, J., Hill, R. A., Jackson, C. F., Khanom, S., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010224.pub3 · Cited by 62
Psychiatric disorders in pregnancy
Levey, L. C., Ragan, K., Hower-Hartley, A., Newport, D. J., & Stowe, Z. N. (2004) · Neurologic Clinics · doi:10.1016/j.ncl.2004.07.003 · Cited by 62
Medical genetics: 1. Clinical teratology in the age of genomics.
Polifka, J. E., & Friedman, J. M. (2002) · Europe PMC (PubMed Central) · Cited by 62
SEIZURE DISORDERS IN PREGNANCY
Pschirrer, E. R., & Monga, M. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70221-7 · Cited by 62
Side effects of phenobarbital in epilepsy: a systematic review
Zhang, L., Zeng, L., & Li, Y. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0444 · Cited by 61
Effects of Antimanic Mood-Stabilizing Drugs on Fetuses, Neonates, and Nursing Infants
IQBAL, M. M., GUNDLAPALLI, S. P., Ryan, W. G., RYALS, T., & Passman, T. E. (2001) · Southern Medical Journal · doi:10.1097/00007611-200103000-00007 · Cited by 61
Kaplan, Y. C., & Demir, Ö. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210211150856 · Cited by 61
Teratogenic effects of antiepileptic drugs
Tomson, T., & Battino, D. (2007) · Seizure · doi:10.1016/j.seizure.2007.11.016 · Cited by 59
Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide
Nucera, B., Brigo, F., Trinka, E., & Kalss, G. (2022) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864221101687 · Cited by 59
Levetiracetam monotherapy during pregnancy: a case series
Long, L. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00122-7 · Cited by 57
Teratogenicity of Antiepileptic Medications
Kluger, B. M., & Meador, K. J. (2008) · Seminars in Neurology · doi:10.1055/s-2008-1079337 · Cited by 54
Teratogenesis of sodium valproate
Duncan, S. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32805866fb · Cited by 54
The Effects of Lithium, Valproic Acid, and Carbamazepine During Pregnancy and Lactation
Iqbal, M. M., Sohhan, T., & Mahmud, S. Z. (2001) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-100105159 · Cited by 54
Pregnancy in the Woman with Epilepsy: Maternal and Fetal Outcomes
Pennell, P. B. (2002) · Seminars in Neurology · doi:10.1055/s-2002-36649 · Cited by 54
Nicolai, J., Vles, J. S. H., & Aldenkamp, A. P. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.03.004 · Cited by 53
Teratogenesis associated with antibipolar agents
Nguyen, H. T., Sharma, V., & McIntyre, R. S. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0011-z · Cited by 53
The teratogenicity of anticonvulsant drugs: a progress report
Holmes, L. B. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.245 · Cited by 53
Houeto, P., Carton, A., Guerbet, M., Mauclaire, A.-C., Gatignol, C., Lechat, P. P., & Masset, D. (2011) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2011.11.012 · Cited by 54
The importance of monotherapy in pregnancy
Pennell, P. B. (2003) · Neurology · doi:10.1212/wnl.60.11_suppl_4.s31 · Cited by 52
Antiepileptic drug combinations not involving valproate and the risk of fetal malformations
Vajda, F. J. E., O'Brien, T. J., Lander, C. M., Graham, J. E., & Eadie, M. J. (2016) · Epilepsia · doi:10.1111/epi.13415 · Cited by 50
Epilepsy during pregnancy: focus on management strategies
Borgelt, L. M., Hart, F., & Bainbridge, J. L. (2016) · International Journal of Women s Health · doi:10.2147/ijwh.s98973 · Cited by 50
Teratogenicity of Antiepileptic Drugs
Güveli, B. T., Rosti, R. Ö., Güzeltaş, A., Tuna, E. B., Ataklı, D., Sencer, S., Yekeler, E., Kayserili, H., Dırıcan, A., Bebek, N., et al. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.1.19 · Cited by 49
Artama, M., Ritvanen, A., Gissler, M., Isojärvi, J. I. T., & Auvinen, A. P. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi234 · Cited by 49
Reproductive health effects and teratogenicity of antiepileptic drugs
Kaplan, P. W. (2004) · Neurology · doi:10.1212/wnl.63.10_suppl_4.s13 · Cited by 49
Special Needs of the Adolescent with Epilepsy
Nordli, D. R. (2001) · Epilepsia · doi:10.1046/j.1528-1157.42.s8.6.x · Cited by 47
Običan, S. G., & Scialli, A. R. (2011) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30310 · Cited by 48
Managing Epilepsy in Women of Childbearing Age
Crawford, P. (2009) · Drug Safety · doi:10.2165/00002018-200932040-00004 · Cited by 46
Folate, homocysteine and methionine loading in patients on carbamazepine
Apeland, T., Mansoor, M. A., Strandjord, R. E., Vefring, H. K., & Kristensen, O. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.103005294.x · Cited by 43
van Woudenberg, A. B., Snel, C. J., Rijkmans, E., de Groot, D., Bouma, M. J., Hermsen, S. A. B., Piersma, A. H., Menke, A. L., & Wolterbeek, A. P. M. (2014) · Reproductive Toxicology · doi:10.1016/j.reprotox.2014.07.082 · Cited by 44
Therapeutic Monitoring of Antiepileptic Drugs during Pregnancy and in the Postpartum Period
Adab, N. (2006) · CNS Drugs · doi:10.2165/00023210-200620100-00001 · Cited by 42
Women are not the same as men: specific clinical issues for female patients with bipolar disorder
Curtis, V. A. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00190.x · Cited by 43
Women with epilepsy: Hormonal issues from menarche through menopause
Cramer, J. A., Gordon, J., Schachter, S., & Devinsky, O. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.03.007 · Cited by 44
Italian Consensus Conference on Epilepsy and Pregnancy, Labor and Puerperium
Aguglia, U., Barboni, G., Battino, D., Cavazzuti, G. B., Citernesi, A., Corosu, R., Guzzetta, F. M., Iannetti, P., Mamoli, D., Patella, A., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01964.x · Cited by 40
Treatment of epilepsy existing therapies and future developments
Aiken, S. P. (2000) · Frontiers in bioscience · doi:10.2741/aiken · Cited by 43
Anticonvulsant Activities of the FS‐1 Subfraction Isolated from Roots of Delphinium denudatum
Raza, M., Shaheen, F., Choudhary, M. I., Suria, A., Rahman, A., Sombati, S., & DeLorenzo, R. J. (2001) · Phytotherapy Research · doi:10.1002/ptr.792 · Cited by 39
Management of epilepsy in women
O’Brien, M. D., & Gilmour-White, S. K. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.030221 · Cited by 39
Divalproex sodium in the treatment of pediatric psychiatric disorders
Rana, M., Khanzode, L. A., Karnik, N. S., Saxena, K., Chang, K., & Steiner, H. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.2.165 · Cited by 38
Katz, J. M., Pacia, S. V., & Devinsky, O. (2001) · Epilepsy & Behavior · doi:10.1006/ebeh.2001.0158 · Cited by 38
Interaction between Anticonvulsants and Human Placental Carnitine Transporter
Wu, S., Shyu, M., Liou, H., Gau, C., & Lin, C. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.29603.x · Cited by 38
Antiepileptic drugs as human teratogens
Eadie, M. J. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.2.195 · Cited by 37
In utero exposure to valproate increases the risk of isolated cleft palate
Jackson, A., Bromley, R., Morrow, J., Irwin, B., & Clayton‐Smith, J. (2015) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2015-308278 · Cited by 37
Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges
EPSTEIN, R. A., Moore, K. M., & Bobo, W. V. (2014) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s50556 · Cited by 38
Meijer, W. M., de Walle, H. E. K., Kerstjens‐Frederikse, W. S., & den Berg, L. T. W. D. J. (2005) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.01.008 · Cited by 37
Patil, M. V. K., Kandhare, A. D., Ghosh, P., & Bhise, S. D. (2012) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-012-0072-4 · Cited by 36
Forsberg, L., Wide, K., & Källén, B. A. J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02778.x · Cited by 36
Galappatthy, P., Liyanage, C. K., Lucas, M. N., Jayasekara, D. T. L. M., Abhayaratna, S., Weeraratne, C., Abrew, K. D., Gunaratne, P. S., Gamage, R., & Wijeyaratne, C. N. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1857-3 · Cited by 38
Atzei, A., Jense, I., Zwart, E., Legradi, J., Venhuis, B. J., van der Ven, L. T. M., Heusinkveld, H. J., & Hessel, E. V. S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18136717 · Cited by 36
Pharmacotherapeutic Issues for Women of Childbearing Age with Epilepsy
Chang, S.-I., & McAuley, J. (1998) · The Annals of Pharmacotherapy · doi:10.1345/aph.17253 · Cited by 34
Management of Epilepsy and Pregnancy
Thomas, S. V., Tomson, T., & Harden, C. L. (2013) · doi:10.1002/9781118531037.ch17 · Cited by 36
Pregnancy in Women with Epilepsy
Laskowska, M., Leszczyńska‐Gorzelak, B., & Oleszczuk, J. (2001) · Gynecologic and Obstetric Investigation · doi:10.1159/000052902 · Cited by 35
Thomas, S. V., Jeemon, P., Pillai, R., Jose, M., Lalithakumari, A. M., Murali, S., Sanalkumar, A., Salini, R. A., & Pavithran, V. (2021) · Seizure · doi:10.1016/j.seizure.2021.10.015 · Cited by 33
Birth Weight in Offspring of Women with Epilepsy
Hvas, C. L., Henriksen, T., & Østergaard, J. R. (2000) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a018039 · Cited by 33
Antiepileptic drug polytherapy in pregnant women with epilepsy
Vajda, F. J. E., O'Brien, T. J., Graham, J. E., Hitchcock, A. A., Lander, C. M., & Eadie, M. J. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.12965 · Cited by 32
Sharma, B., Verma, A., Sharma, U. K., & Prajapati, S. K. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0618-0 · Cited by 32
Pregnancy and epilepsy: what should we tell our patients?
Tomson, T., & Battino, D. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5062-1 · Cited by 32
Using Current Evidence in Selecting Antiepileptic Drugs for Use during Pregnancy
Pennell, P. B. (2005) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7597.2005.05201.x · Cited by 30
Is carbamazepine a human teratogen?
Vajda, F. J. E., O'Brien, T. J., Graham, J. E., Lander, C. M., & Eadie, M. J. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.07.011 · Cited by 29
van der Maas, N., Dijs-Elsinga, J., Kemmeren, J. M., van Lier, A., Knol, M. J., & de Melker, H. E. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13329 · Cited by 29
Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications
Dolk, H. M., & McElhatton, P. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.243 · Cited by 29
UPLC–TOF-MS analysis of Galium spurium towards its neuroprotective and anticonvulsant activities
Orhan, N., Orhan, D. D., Aslan, M., Sukuroglu, M. K., & Orhan, İ. E. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.01.056 · Cited by 28
Rauchenzauner, M., Deichmann, S., Pittschieler, S., Bergmann, M., Prieschl, M., Unterberger, I., Rösing, B., Seger, C., Möser, C., Wildt, L., et al. (2019) · Seizure · doi:10.1016/j.seizure.2019.11.011 · Cited by 28
The prescribing of antiepileptic drugs for pregnant Australian women
Vajda, F. J. E., Horgan, D., Hollingworth, S., Graham, J. E., Hitchcock, A. A., Roten, A., O'Brien, T. J., LANDER, C. M., & Eadie, M. J. (2011) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2011.01359.x · Cited by 28
Antiepileptic drugs and neurodevelopment
Motamedi, G. K., & Meador, K. J. (2006) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-006-0028-5 · Cited by 28
Mostacci, B., Ranzato, F., Giuliano, L., Neve, A. L., Aguglia, U., Bilo, L., Durante, V., Ermio, C., Monti, G., Zambrelli, E., et al. (2020) · Seizure · doi:10.1016/j.seizure.2020.12.005 · Cited by 27
Human placental perfusion method in the assessment of transplacental passage of antiepileptic drugs
MYLLYNEN, P., Pienimäki, P., & Vähäkangas, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.042 · Cited by 27
U.K. Epilepsy and Pregnancy Group
Russell, A., Craig, J. J., Morrison, P. J., Irwin, B., Waddell, R., Parsons, L., Robertson, I., Guthrie, E., & Morrow, J. I. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.451104.x · Cited by 27
Anti-epileptic drugs in pregnancy: current safety and other issues
Morrow, J., & Craig, J. J. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.4.445 · Cited by 27
Use of antiepileptic drugs in pregnancy
Tatum, W. O. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.1077 · Cited by 26
Management of women with epilepsy during pregnancy
Adab, N., & Chadwick, D. W. (2006) · The Obstetrician & Gynaecologist · doi:10.1576/toag.8.1.020.27204 · Cited by 26
Neurological teratogenic effects of antiepileptic drugs during pregnancy
Nie, Q., Su, B., & Wei, J. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3628 · Cited by 26
Bioavailability Enhancement of Poorly Soluble Drugs: The Holy Grail in Pharma Industry
Rashid, M., Malik, M. Y., Singh, S. K., Chaturvedi, S., Gayen, J. R., & Wahajuddin, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190130110653 · Cited by 28
Should valproate be taken during pregnancy?
Eadie, M. J., & Vajda, F. J. E. (2005) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.1.1.21.53605 · Cited by 26
Management of Epilepsy in Women of Childbearing Age
Tettenborn, B. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00003 · Cited by 26
EFSA Panel on Food Contact Materials, E. (2012) · EFSA Journal · doi:10.2903/j.efsa.2012.2563 · Cited by 25
Keni, R. R., Jose, M., Reshma, A. S., Baishya, J., Sarma, P. S., & Thomas, S. V. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.106250 · Cited by 25
Tomson, T. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0344-0 · Cited by 25
Classifying epilepsy pragmatically: Past, present, and future
Shlobin, N. A., Singh, G., Newton, C. R. J. C., & Sander, J. W. A. S. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117515 · Cited by 24
SCN1A-Related Seizure Disorders
Miller, I., & de Menezes, M. A. S. (2014) · Cited by 23
A survey of antiepileptic prescribing to women of childbearing potential in psychiatry
Wieck, A., Rao, S., Sein, K. K., & Haddad, P. M. (2007) · Archives of Women s Mental Health · doi:10.1007/s00737-007-0175-y · Cited by 23
Anticonvulsants and drugs for neurological disease
Lowe, S. A. (2001) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2001.0234 · Cited by 23
Antiepileptic drugs ( AED s) during pregnancy and risk of congenital jaw and oral malformation
Koo, J., & Zavras, A. I. (2012) · Oral Diseases · doi:10.1111/odi.12061 · Cited by 21
Teratogenic effects of lamotrigine on rat fetal brain: a morphometric study
de Marchi, N. S. A., Azoubel, R., & Tognola, W. A. (2001) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2001000300010 · Cited by 21
Genetics of epilepsy: Epilepsy Research Foundation workshop report
Sisodiya, S. M., Cross, J. H., Blümcke, I., Chadwick, D. W., Craig, J. J., Crino, P. B., Debenham, P., Delanty, N., Elmslie, F., Gardiner, M., et al. (2007) · Epileptic Disorders · doi:10.1684/epd.2007.0107 · Cited by 21
Bruno, M. K., & Harden, C. L. (2002) · Current Treatment Options in Neurology · doi:10.1007/s11940-002-0003-7 · Cited by 21
Antiepileptic drug therapy during pregnancy: the neurologist's perspective
Shorvon, S. D. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.248 · Cited by 21
Bulletin, A. P. (2009) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.7.3.foc385 · Cited by 19
Drug???Induced Congenital Defects
Santis, M. D., Carducci, B., Cavaliere, A. F., Santis, L. D., Straface, G., & Caruso, A. (2001) · Drug Safety · doi:10.2165/00002018-200124120-00003 · Cited by 19
Role of valproate across the ages. Treatment of epilepsy in adults
Ben‐Menachem, E., Schmitz, B., Tomson, T., & Vajda, F. J. E. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00667.x · Cited by 18
Hearing and speech impairment at age 4 and risk of later non-affective psychosis
Fors, A., Abel, K. M., Wicks, S., Magnusson, C., & Dalman, C. (2012) · Psychological Medicine · doi:10.1017/s0033291712002644 · Cited by 18
Graf, W. D., Kekatpure, M. V., & Kosofsky, B. E. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52891-9.00014-2 · Cited by 19
Neurodevelopmental effects of anti-epileptic drugs
Cross, J. H. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.08.015 · Cited by 18
Lexikon der Syndrome und Fehlbildungen
Witköwski, R., Prokop, O., & Ullrich, E. (1999) · Springer eBooks · doi:10.1007/978-3-642-98007-7_6 · Cited by 17
Langan, J., Perry, A., & Oto, M. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-234 · Cited by 17
Åberg, E., Holst, S., Neagu, A., Ögren, S. O., & Lavebratt, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080497 · Cited by 16
Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero
Sorri, I., Herrgård, E. A., Viinikainen, K., Pääkkönen, A. K., Heinonen, S. T., & Kälviäinen, R. K. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.04.001 · Cited by 16
Out of sight, out of mind? Germ cells and the potential impacts of epigenomic drugs
Jarred, E. G., Bildsoe, H., & Western, P. S. (2018) · F1000Research · doi:10.12688/f1000research.15935.1 · Cited by 17
Metadata
- Authors
- Samrén, E. B., van Duijn, C. M., Koch, S., Hiilesmaa, V. K., Klepel, H., Bardy, A. H., Mannagetta, G. B., Deichl, A. W., Gaily, E., Granström, I. L., Meinardi, H., Grobbee, D. E., Hofman, A., Janz, D., & Lindhout, D.
- Affiliations
- Erasmus MC (NL)
- Helsinki University Hospital (FI)
- University Hospital Magdeburg (DE)
- University of Helsinki (FI)
- Stichting Epilepsie Instellingen Nederland (NL)
- Corresponding author
- Lindhout, D.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 1997-09
- Volume
- 38
- Issue
- 9
- Pages
- 981-990
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2143268844
- Cited by
- 406
- References
- 46
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 10 · 2017: 9 · 2016: 11 · 2015: 22 · 2014: 16 · 2013: 17 · 2012: 16
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Epilepsia (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- Sanofi
- Deutsche Forschungsgemeinschaft
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- antiepileptic drugs, major congenital malformations, maternal epilepsy, valproic acid, carbamazepine, phenytoin, phenobarbital, ethosuximide, polypharmacy, monotherapy, neural tube defects, prenatal drug exposure, dose-response relationship, pregnancy outcomes
- MeSH terms
- Abnormalities, Drug-Induced, Adolescent, Adult, Anticonvulsants, Dose-Response Relationship, Drug, Drug Therapy, Combination, Epilepsy, Female, Humans, Infant, Newborn, Male, Maternal-Fetal Exchange, Middle Aged, Pregnancy, Pregnancy Complications, Prospective Studies, Risk Factors, Cohort Studies, Multicenter Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review